Clinical factors associated with achieving K/DOQI hemoglobin targets in hemodialysis patients (Q44908499)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Clinical factors associated with achieving K/DOQI hemoglobin targets in hemodialysis patients	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Clinical factors associated with achieving K/DOQI hemoglobin targets in hemodialysis patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Suying Li

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Robert N Foley

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

David T Gilbertson

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Jiannong Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Allan J Collins

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

International Urology and Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

399-405

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Clinical characteristic of parenteral iron supplementation in hemodialysis patients receiving erythropoietin therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15160548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

2001 Annual Report: ESRD Clinical Performance Measures Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/15160548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Duration of dialysis and its relationship to dialysis adequacy, anemia management, and serum albumin level

1 reference

https://pubmed.ncbi.nlm.nih.gov/15160548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15160548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period

1 reference

https://pubmed.ncbi.nlm.nih.gov/15160548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gender modulates responsiveness to recombinant erythropoietin

1 reference

https://pubmed.ncbi.nlm.nih.gov/15160548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous erythropoietin results in lower dose and equivalent hematocrit levels among adult hemodialysis patients: Results from the 1998 End-Stage Renal Disease Core Indicators Project.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15160548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%

1 reference

https://pubmed.ncbi.nlm.nih.gov/15160548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000

1 reference

https://pubmed.ncbi.nlm.nih.gov/15160548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15160548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/15160548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematocrit levels and associated Medicare expenditures

1 reference

https://pubmed.ncbi.nlm.nih.gov/15160548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of erythropoietin before the initiation of dialysis and its impact on mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/15160548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends in anemia treatment with erythropoietin usage and patient outcomes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15160548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time-related increase in hematocrit on chronic hemodialysis: uncertain role of renal cysts

1 reference

https://pubmed.ncbi.nlm.nih.gov/15160548

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/B:UROL.0000022951.17591.0B

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44908499&oldid=2056702704"